Gibco™ Human Skeletal Myoblasts (HSkM)

Description

Human Skeletal Myoblasts

Primary Normal Human Skeletal Myoblasts (HSkM) are designed to undergo highly efficient differentiation directly following plating of cryopreserved cells. Each vial contains cells that have been cryopreserved in a medium containing 10% DMSO and will differentiate within 48 hours after plating. These cells do not require expansion prior to differentiation. Cell viability is >70% post thaw with a ≥50% myogenic index after 48 hours. Intended for use by researchers investigating the molecular and biochemical bases of various normal and disease processes. They are compatible with Bacmam delivery technologies for various downstream applications. Large size contains 4.5 x 10^6 ≤ N ≤ 7.5 x 10^6 cells per vial and small size contains 1.1 x 10^6 ≤ N ≤ 1.9 x 10^6 cells per vial.

Primary Normal Human Skeletal Myoblasts (HSkM) are designed to undergo highly efficient differentiation following plating of cryopreserved cells.

The cells are:

• Performance tested—guaranteed to differentiate ≥ 50% following 48 hours of incubation
• Guaranteed to be ≥ 70% viable
• Tested for mycoplasma, bacteria, yeast or other fungi, hepatitis B, hepatitis C, and HIV-1 viruses

Each vial contain sufficient number of cells to fully seed a single multi-well dish (ranging in format from 6-well to 384-well).

Specifications

• Content And Storage: Store in liquid nitrogen.
• Age: Adult
• Cell Type: Skeletal Muscle Cells
• Culture Type: Adherent Cell Culture
• Form: Cryopreserved
• Gender: Mixed Gender
• Species: Human
• Donor Attributes: Normal
• Donor Source: Single Donor
• Format: Vial
• No. of Cells: 1 x 10^6
• Product Line: Gibco™
• Product Type: Human Skeletal Myoblast
• Quantity: 1 vial x 10⁶ cells
• Tested For: Mycoplasma, Bacteria, Yeast or Other Fungi, Hepatitis B, Hepatitis C, HIV-1 Virus

Safety and Handling

WARNING: Reproductive Harm - www.P65Warnings.ca.gov

For Research Use Only. Not for use in diagnostic procedures.